Changing the Practice of Medicine
Popular
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Alessandra Tedeschi, MD
Aditya Bardia, MD, MPH, FASCO
- CME/CE Broadcast Replay
A Q-Challenge™ Replay: Advancing Precision Diagnosis and Treatment Strategies in Acromegaly
1.00 creditMaria Fleseriu, MD, FACE
Shlomo Melmed, MBChB
Elise M. Brett, MD, FACE
- MinuteCE®
Before the Scalpel: Identifying Candidates for Perioperative Immunotherapy
0.50 program creditsAdam J. Luginbuhl, MD
- MinuteCE®
Choosing the Path Forward: A Real-World Dialogue on Perioperative Immunotherapy
0.50 program creditsAdam J. Luginbuhl, MD
CME/CE
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Florence Odufalu, MD
Ugo Iroku, MD, MHS
- MinuteCE®
IBD Care Reimagined: Personalized, Proactive, and Target-Driven Management
2.00 credits 3 episodesDavid T. Rubin, MD
Michael Dolinger, MD, MBA
Florence Odufalu, MD
Ugo Iroku, MD, MHS
Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP
- CME/CE Broadcast Replay
Seeing the Invisible: Radiologic Precision to Enable Early Intervention in Bronchiectasis
1.00 creditRobert D. Suh, MD
Ashwin Basavaraj, MD
Mary Salvatore, MD, MBA
Jennifer Johnson, MD, PhD
Adam J. Luginbuhl, MD
Jennifer Johnson, MD, PhD
Clinical Practice
Jennifer Johnson, MD, PhD
Jennifer Johnson, MD, PhD
Adam J. Luginbuhl, MD
David T. Rubin, MD
Michael Dolinger, MD, MBA
Enriqueta Felip, MD
Kristi Orbaugh, MSN, RNP, AOCN
David T. Rubin, MD
Ugo Iroku, MD, MHS
Florence Odufalu, MD
Programs
- Oncology and Hematology
TROPION-Breast02: Evidence for the Approval of Datopotamab Deruxtecan for Patients With mTNBC Ineligible for Immunotherapy
Tiffany Traina, MD, FASCO
- Oncology and Hematology
DESTINY-Breast11: Trastuzumab Deruxtecan Followed by THP Yields New Indication in the Neoadjuvant Setting.
Sara A. Hurvitz, MD, FACP
Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP
Florence Odufalu, MD
Michael Dolinger, MD, MBA
David T. Rubin, MD
Ugo Iroku, MD, MHS
Roger A. Goldberg, MD, MBA
Christina Y. Weng, MD, MBA, FASRS
Yasha S. Modi, MD